| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.098 | 0.03 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |